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ABSTRACT 
 ATP-sensitive potassium channels 
(KATP) contribute to membrane currents in 
many tissues, are responsive to intracellular 
metabolism, and open as ATP falls and ADP 
rises. KATP channels are widely distributed in 
tissues and are prominently expressed in the 
heart. They have generally been observed in 
ventricular tissue, but they are also expressed 
in the atria and conduction tissues. In this 
study, we focused on the contribution and role 
of the inwardly rectifying KATP channel 
subunit, Kir6.1, in the sinoatrial node (SAN). 
To develop a murine, conduction-specific 
Kir6.1 KO model, we selectively deleted the 
Kir6.1 in the conduction system in adult mice 
(cKO). Electrophysiological data in single 
SAN cells indicated that Kir6.1 underlies a 
KATP current in a significant proportion of cells 
and influences early repolarization during 
pacemaking, resulting in prolonged cycle 
length. Implanted telemetry probes to measure 
heart rate and electrocardiographic  
characteristics revealed that the cKO mice 
have a slow heart rate, with episodes of sinus 
arrest in some mice. The PR interval was 
increased, suggesting effects on the 
atrioventricular node. Ex vivo studies of whole 
heart or dissected heart regions disclosed 
impaired adaptive responses of the SAN to 
hypoxia, and this may have had long-term 
pathological consequences in the cKO mice. In 
conclusion, Kir6.1-containing KATP channels 
in the SAN have a role in excitability, heart 
rate control, and the electrophysiological 
adaptation of the SAN to hypoxia.  
    
INTRODUCTION  
 ATP sensitive potassium channels 
(KATP) contribute to membrane currents in a 
number of tissues. They are opened by falling 
cellular ATP and\or rising ADP levels and are 
important metabolic sensors (1). Substantial 
KATP currents were first described in 
cardiomyocytes and then subsequently in 
pancreatic beta cells, skeletal muscle, smooth 
muscle cells and neurones (2,3). KATP channels 
are critical in mediating a number of 
physiological processes. For example, they are 
central in stimulus secretion coupling 
underlying insulin release from the endocrine 
pancreas (4). At the molecular level the 
channel is a hetero-octamer of four 
sulphonylurea receptors (SUR1, SUR2A) and 
four pore forming inwardly rectifying Kir6.0 
subunits (Kir6.1, Kir6.2) (5-7). Recent ground 
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breaking structural studies using cryo-electron 
microscopy have suggested models for how 
the channels are able to sense nucleotides at 
the molecular level (8,9).    
Ironically, despite the initial 
description of the KATP current in 
cardiomyocytes and the substantial current 
density in ventricular cells, it is less clear as to 
the physiological role this channel plays in 
cardiac function (1). Mice with global genetic 
deletion of Kir6.2, which is thought to underlie 
ventricular cardiac KATP currents, have 
impaired exercise tolerance and cardiac 
performance under sympathetic stimulation 
suggesting a role in adaptation of the myocyte 
to the metabolic demands of exercise (10). 
Furthermore, KATP currents are present in other 
chambers in the heart including the atria and 
conduction system (11,12). Indeed these 
currents may have unique subunit composition 
and properties.  
The sinoatrial node (SAN) is the 
dominant pacemaker in the mammalian heart 
and has unique electrophysiological 
characteristics underlying this role. There have 
been few studies on KATP currents in these 
cells but it is clear they exist and may at least 
partially be based upon Kir6.2 subunit 
expression (13). However Kir6.1 containing 
channels may also have a role. Global Kir6.1 
knockout mice die prematurely from SAN 
failure and heart block. Initially this was 
attributed to loss of KATP channels in coronary 
vascular smooth muscle leading to vasospasm 
and cardiac ischaemia (14). However, we have 
generated mice in which it is possible to 
selectively delete Kir6.1 in various tissues and 
at various times using cre\loxP technology 
(15,16). Mice with deletion in vascular smooth 
muscle or endothelium do not recapitulate this 
phenotype suggesting there may be a direct 
role for Kir6.1 containing KATP channels in the 
conduction system (15,16). In this study we 
explore this idea by using cre\loxP technology 
using our previously described mice and 
crossing them with a cre recombinase murine 
line that allows selective deletion in the 
cardiac conduction system after the 
administration of tamoxifen (17) 
 
RESULTS 
Generation of the conduction-specific Kir6.1 
KO mouse - HCN4cre+ Kir6.1(flx/flx) (cKO) 
mice were generated by crossing 
Kir6.1(flx/flx) mice with a conduction system-
specific cre into which the tamoxifen-
inducible Cre-ERT2 had been ‘knocked-in’ into 
the HCN4 locus (see Methods and Figure 1A) 
(15,16) (17). PCR confirms the presence of cre 
recombinase (900 bp) at the genomic level in 
ear tissue from HCN4cre+ Kir6.1(flx/flx) mice 
but not in that of control animals (WT) (Figure 
1B). The “floxed” allele is recognised by a 
PCR reaction spanning exon1, the 5’ loxP site 
and the recombined FRT site and associated 
sequence. In the “floxed” mouse this leads to a 
600 bp product whilst it generates a 474 bp 
product in the WT allele (which does not 
include these additional sequence elements) 
(Figure 1B). The occurrence of the 
recombination event in HCN4cre+ 
Kir6.1(flx/flx) mice selectively in the SAN 
following tamoxifen induction was confirmed 
using PCR on genomic DNA isolated from 
SAN, atria and ventricles (Figure 1B). 
 To confirm the reduced expression of 
Kir6.1 (Kcnj8) in the SAN of cKO mice, 
quantitative real-time PCR was used on RNA 
isolated from SAN, atria and ventricles from 
cKO and littermate controls post-tamoxifen 
administration (Figure 1C). Kir6.1 expression 
was reduced by ~50% in SAN of cKO mice 
compared to WT SAN (n=5, P<0.01). 
Expression of Kir6.1 was unaffected in both 
atria and ventricles confirming conduction 
system-specific deletion (P>0.05). 
Interestingly, expression of Kir6.2 (Kcnj11) in 
SAN was increased by ~50% suggesting 
possible compensation for Kir6.1 deletion 
(n=5, P<0.01). SUR1 (Abcc8) and SUR2 
(Abcc9) expression was unchanged in any of 
the cKO tissues assayed compared to WT 
(n=5, P>0.05). 
Kir6.1 deletion reduces the KATP current in 
acutely-isolated SAN cells from cKO mice - To 
investigate if the deletion of Kir6.1 in the SAN 
has functional consequences, we subjected 
acutely isolated SAN cells from cKO and WT 
mice to whole-cell patch clamping (Figure 2). 
The KATP current in the SAN has not been 
extensively characterised so some basic 
pharmacological experiments were first 






































express a pinacidil/diazoxide-sensitive current 
(15/29 cells, n=29 cells from 6 mice). Of the 
WT cells that did express a KATP current, ~7 % 
were responsive to pinacidil whilst ~41% were 
activated by diazoxide (Figure 2). In cells from 
cKO mice, ~4% and ~11% responded to 
pinacidil and diazoxide, respectively, (n=28 
cells from 4 mice, P=0.015 for diazoxide 
sensitivity when compared to WT). Both 
pinacidil and diazoxide sensitive currents were 
inhibited by tolbutamide. These data suggest 
that a KATP channel comprising Kir6.1 is 
present in a proportion of SAN cells and that it 
is predominantly activated by diazoxide and 
inhibited by tolbutamide. 
Kir6.1 cKO mice have a bradycardic 
phenotype - The potential physiological 
consequences of Kir6.1 deletion in SAN on 
heart rate and rhythm were then studied. ECG 
radio-telemetry was used in conscious freely-
moving WT and cKO mice (Figure 3). Both 
WT and cKO mice showed a diurnal variation 
in heart rate before and after tamoxifen 
induction (P< 0.01 compared night to day). 
HR, RR and PR interval were not significantly 
different before and after tamoxifen 
administration in ECG recordings from 
littermate control mice (n=5, P>0.05). 
Conversely, cKO mice developed a 
bradycardic phenotype following 
administration of tamoxifen with significant 
changes in HR, PR and RR interval both 
during the day and night (n=8, P>0.05). HR 
decreased by ~50 bpm during the day and at 
night and this was reflected in an increase in 
both RR and PR intervals. A closer 
investigation of the ECG recordings revealed a 
much more severe bradycardic phenotype in 
3/8 cKO mice (Figure 3E). In these mice, there 
were pronounced bradycardic episodes with 
evidence of sinus pauses reflected in RR 
intervals of greater than 1 second in some 
instances. We quantified these episodes by 
counting the number of RR intervals greater 
than 200 ms in all mice following tamoxifen 
induction (Figure 3F). cKO mice had a greater 
frequency of prolonged beats compared to WT 
mice (P<0.01).  
 The change in heart rate in cKO mice 
was further investigated by carrying out heart 
rate variability (HRV) analysis (Figure 4). We 
looked at ECG recordings during a period of 
low activity (12-2pm) to analyse possible 
changes in autonomic influence in HRV. 
Frequency domain analysis showed no change 
in HRV in WT and cKO mice following 
tamoxifen induction (n=5, P>0.05). There was 
no change in the power of both low (0.4-1.5 
Hz) and high (1.5-4 Hz) frequency spectra or 
the total power suggesting that the deletion of 
Kir6.1 from the conduction system does not 
grossly affect autonomic control of heart rate. 
Action potential duration is prolonged in 
isolated SAN cells from cKO mice - The 
effects of conduction-specific Kir6.1 deletion 
on spontaneous SAN action potentials were 
investigated using current-clamp (Figure 5). 
Deletion of Kir6.1 reduced the firing rate of 
spontaneous action potentials in cKO SAN 
cells but did not change SAN cell resting 
membrane and maximum diastolic potential 
(Figure 5 and Table 1). Initial upstroke 
velocity was unchanged but time-to-peak was 
increased in cKO mice (n=11-15 cells from 7-
9 mice, P<0.05). Repolarisation was delayed 
throughout the action potential but particularly 
during early repolarisation (Figure 5). This 
was reflected in a ~50% decrease in the action 
potential duration (APD) ratio, APD90/50 
(P<0.005) and an increase in the APD30-
40/APD70-80 ratio (P<0.05) in SAN cells 
from cKO mice (Figure 5F and G). These data 
suggest that deletion of Kir6.1 changes the 
duration and shape of the SAN action potential 
but does not contribute significantly to resting 
membrane potential in these cells. 
 To investigate the phenotype further 
in-vitro, MEAs were used to measure 
spontaneous field potentials in SAN/atrial 
preparations from WT and cKO mice (Figure 
6A and B). MEA recordings showed a 
significantly reduced beating frequency in 
preparations from cKO mice compared to WT 
mice (n=12, P<0.05). In support of these 
observations, SAN cells acutely isolated from 
cKO mice after tamoxifen administration have 
a lower beat frequency (Figure 5B). Both these 
ex-vivo studies indicate that the observed 
bradycardia in in-vivo experiments results 
from properties intrinsic to the SAN myocytes 
following deletion of Kir6.1. 
Sinus node recovery time (SNRT) is prolonged 
and its adaptation to stress is compromised in 






































intact heart we used a flexMEA to measure the 
SNRT in the Langendorff-perfused heart 
(Figure 6C-E). SNRT, following pacing with 
S1-S1 intervals of 100 ms, was significantly 
increased in cKO mouse hearts compared to 
WT hearts (n=10-12, P<0.05) suggesting 
potential SAN dysfunction in cKO mice. KATP 
channels are known to be protective against 
metabolic challenge (1). To investigate if 
deletion of Kir6.1 in the SAN changes 
adaptation to stress, we challenged WT and 
cKO hearts with hypoxia (Krebs bubbled with 
95% N2\5% CO2) and measured the SNRT. In 
WT hearts SNRT was increased following 10 
minutes of hypoxia (Figure 6E, P<0.05 
compared to control). Interestingly, hypoxia 
had no effect on SNRT in cKO hearts 
(P>0.05). SNRT of WT hearts returned close 
but not completely to basal levels following 10 
minutes of reperfusion.  
Increased expression of pro-fibrotic markers 
in hypomorphic cKO SANs - We examined 
whether deletion of Kir6.1 in the SAN had 
long-term consequences for SA node 
morphology and pathology. Masson’s 
trichome staining was used to investigate if 
Kir6.1 deletion increases fibrosis and changes 
the morphology of the SAN in cKO mice 
(Figure 7). The SA node appeared smaller and 
thinner in SAN sections from cKO mice, with 
fewer viable myocytes. There was more 
fibrous tissue compared to WT SANs. To 
quantify these observations RT-qPCR was 
performed for known fibrosis-related genes. 
An increase in expression of a number of pro-
fibrotic markers within cKO SANs was 
observed (Figure 7C). Specifically, the 
expression of genes for collagen (Col1a3), 
Tgf-β1 and Tgf-β2 were significantly 
increased by ~50 % (n=5, P<0.05). These data 
suggest that deletion of Kir6.1 in the SAN can 
lead to an increase in pro-fibrotic markers and 
fibrosis. We also examined if there were any 
changes in expression of ion channels other 
than Kir6.1 in the cKO mice indicative of a 
remodelling process. We used RT-qPCR (n=4 
mice, mean from triplicate measurements of 
CT) to measure the expression of Hcn4 
(WT7.73±0.46; cKO 7.52±0.16), Hcn1 
(WT8.77±0.28; cKO 7.70±0.62), Kcnj3 (WT 
4.37±0.23; cKO 3.93±0.43), Kcnj5 (WT 
5.68±0.29; cKO 4.75±0.42), Cacna1c (WT 
8.09±0.17; cKO 7.66±0.25), Cacna1g (WT 
7.16±0.19; cKO 7.09±0.41) and Cacna1h 
(cWT5.79±0.15; cKO 6.03±0.32). There are 
no significant differences between the 
expression values for the ion channel 
transcripts (P>0.05, one way ANOVA with a 
Sidak’s multiple comparison test).    
 
DISCUSSION  
 Using a novel murine model we have 
deleted the KATP channel subunit Kir6.1 in the 
SAN. Uniquely, our data indicate that Kir6.1 
underlies a KATP current in a proportion of 
SAN cells and influences repolarisation during 
the spontaneous action potential. This leads to 
mice having a bradycardic phenotype with 
episodes of sinus arrest in some mice, changes 
intrinsic to the SAN. Furthermore, the 
impaired adaptive responses of the SAN to 
hypoxia suggest the KATP channel promotes 
protection in these conditions. Our studies 
define a novel and little appreciated 
contributor to mammalian pacemaking.   
 Comparatively little literature exists 
on the nature of KATP channels in the SAN. In 
rabbit SAN cells the potassium channel 
openers pinacidil and cromakalim abolished 
pacemaker activity through membrane 
hyperpolarisation (18). Electrophysiological 
studies identified an ATP-sensitive current 
with a unique single channel conductance of 
~50 pS rather than one closer to the 80 pS 
found for channels in ventricular cells (18). In 
mice with global genetic deletion of Kir6.2 the 
SAN in the intact perfused heart no longer 
responded to hypoxia with an increase in 
coupling length (13). Our data show that a 
prominent KATP current could be demonstrated 
in ~50% of murine SAN myocytes This is 
perhaps not surprising as the SAN is a 
heterogeneous structure and a number of 
different cell types and regions can be 
distinguished (19,20). In these studies, the 
number of cells containing KATP currents was 
significantly reduced (yet not wholly 
abolished) in cKO mice indicating that Kir6.1 
is a major contributor to these membrane 
currents. The single-channel conductance 
observed by Han and colleagues is closer to 
that reported for Kir6.1 containing complexes 
or that for various heteromultimers between 






































is also interesting with diazoxide more 
frequently activating these currents whilst 
tolbutamide as well as glibenclamide can 
inhibit the responses. This is more 
representative of SUR1 containing KATP 
channel complexes than SUR2, though 
diazoxide can act on SUR2B containing 
hetero-octamers (22). SUR1 containing KATP 
channels are already known to be present in 
murine atrial myocytes (23). In cKO mice 
there was an increase in Kir6.2 expression as 
assessed by RT-qPCR but not in SUR1 or 
SUR2 expression. Furthermore, KATP currents 
were essentially abolished with no response to 
diazoxide and only a very few cells, 
comparable with controls, responding to 
pinacidil. Thus the increased expression of 
Kir6.2 mRNA does not have prominent 
functional sequelae.      
 The cKO mice are clearly bradycardic 
when assayed by three independent assays: 
single cell, ex-vivo and in-vivo studies. In the 
latter studies, no evidence was found 
supporting changes in autonomic or hormonal 
influences on heart rate in the cKO mice. In 
other words, the process observed was solely 
intrinsic to the SA node, as would be expected 
from the specificity of expression of the cre 
recombinase.  
 Our action potential recordings 
demonstrate an increase in action potential 
duration particularly prominent during the 
early stages of repolarisation. Thus, even 
under resting conditions and without metabolic 
challenge, Kir6.1 containing KATP channels are 
active and contribute to potassium currents 
involved in shaping the SAN action potential. 
Furthermore, the maximum diastolic 
depolarisation and resting membrane potential 
were not prominently changed in knockout 
animals. The time-to-peak depolarisation was 
also delayed in the cKO mice. The net upshot 
of these cumulative effects is a prolongation of 
the action potential. Given an equivalent or 
unchanged time-period for diastolic 
depolarisation, a consequence would be to 
increase the SAN cycle length and thus 
decrease heart rate.  
 KATP currents generated by Kir6.1 
containing subunits are actually outwardly 
rectifying (see above). However currents do 
not deactivate with hyperpolarisation, as 
would a classic voltage-gated potassium 
channel, and it is surprising that they do not 
have a significant influence on the pacemaker 
depolarisation. It is known that cAMP 
signalling is highly developed in the SAN (24) 
and it is possible that phasic oscillations in 
PKA activity might amplify the KATP current 
during repolarisation. PKA is known to 
prominently regulate Kir6.1 containing 
channel complexes(25). However there is 
precedent for analogous observations in the 
literature: deletion of the gene encoding 
TREK-1, a background potassium current, led 
to sinus bradycardia and pauses (26).   
 The HCN4 promoter driven cre is also 
active in other regions of the conduction 
system. Although a formal investigation of this 
fell outside of the scope of this study, an 
increase in PR interval on the ECG reflective 
of delayed AV nodal conduction was observed 
in these animals. This implies that Kir6.1 also 
plays a role in the physiological function of the 
AV node. Indeed, gain of function mutations 
in the Kir6.1 subunit found in patients with 
Cantu syndrome and mouse models with 
Kir6.1 gain of function show AV conduction 
abnormalities (27,28).  
 In the global Kir6.1 knockout mouse 
one of the major contributors to premature 
death is sudden cardiac death due to 
bradyarrhythmia resulting from sinus arrest 
and heart block (14,15). Selected cKO mice 
displayed features of this phenomenon, but not 
as prominently as in the global knockouts. 
Opening of KATP channels can contribute to 
cellular protection in several pathological 
conditions (1,29). We therefore examined the 
response of the SAN to hypoxia in ex-vivo 
intact hearts, using sinus nodal recovery from 
burst pacing, (SNRT) as a comparison metric. 
In wildtype littermate controls the SNRT was 
prolonged by hypoxic challenge whilst in the 
cKO mice this did not occur. It is plausible 
that this response by the SAN is protective as 
it allows some degree of electrical silencing in 
conditions of metabolic challenge. The 
electrical silencing likely occurs through 
action potential failure due to overwhelming 
repolarising currents. This will prevent cellular 
calcium overload and cell death. The observed 
hypoplasia of the SA node and increased 






































hypothesis of cell death and fibrosis in cKO 
mice. It is difficult to unambiguously separate 
the functional effects of a direct effect of 
Kir6.1 deletion and the pathological changes 
seen in SAN on SAN electrophysiology. We 
think both contribute however it is worth 
noting that we have performed single cell 
studies on SAN myocytes where a reduced 
spontaneous firing rate is present in cKO mice 
and the relative change in heart rate in the 
knockout is similar to that in the ex-vivo and 
in-vivo studies. It is also possible that the 
fibrotic process leads to remodelling of ion 
channel expression in the SAN. Thus we 
examined the expression of a selected number 
of ion channels in the SAN using RT-qPCR. 
We did not find prominent changes in 
expression between wildtype control SAN 
cells and those with deletion of Kir6.1.  
 The more severe electrophysiological 
phenotype seen in global Kir6.1 knockout 
mice can be explained by likely episodes of 
coronary vasospasm leading to hypoxia in the 
SAN combining with failures of appropriate 
protective responses. The phenotype in the 
cKO mice is milder and sinus arrest occurs in 
only a limited number of mice. However, the 
primacy of the cardiac electrophysiology 
effect is supported by the observation that a 
pure vascular phenotype, as in a murine line 
with specific smooth muscle deletion, did not 
display a bradycardiac phenotype under 
resting conditions or with ergonovine (15). It 
is interesting that sudden infant death 
syndrome has been associated with loss of 
function mutations in KCNJ8 (30).     
 This study is the first to formally 
define the role of Kir6.1 in the sinus node, and 
significantly adds to the understanding of the 
complexities of sinus node physiology. 
However, there are several limitations to this 
study. First, this study investigated the murine 
SAN given that cre/loxP technology is as yet 
not easily replicated in other species. 
Mutations in Kir6.1 have been implicated in 
causing atrial fibrillation and early 
repolarisation syndromes in man (31,32). 
However there are data indicating that Kir6.1 
may be expressed more widely in murine 
cardiac tissue than in man for example (33) 
and this may confound translation to human 
disease. Second, although we found evidence 
for the cellular protective effects of Kir6.1, we 
have not performed long term aging studies 
that may be required to fully define the precise 
molecular effects on these pathways.  
 In conclusion, we show that KATP 
channels constituted of Kir6.1 are present in 
SAN and influence repolarisation. Cycle 
length is prolonged resulting in bradycardia in 
cKO mice. In addition, these channels may 
also protect against sinus node dysfunction for 
example during hypoxic conditions.    
 
EXPERIMENTAL PROCEDURES 
Animal husbandry - All experiments were 
conducted in accordance with the Guide for 
the Care and Use of Laboratory Animals 
published by the British Home Office and the 
US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996). The 
animal work was approved by the QMUL 
Animal Welfare and Ethical Review Body and 
covered by UK Home Office project licences 
PPL/6732 and PPL/7665. 
Generation of conduction system-specific 
Kir6.1 KO mice - Kir6.1 flx/wt mice were 
generated in our lab in collaboration with 
Genoway (Lyon, France; project number 
genOway/EV/TIN1- Kcnj8 070206). The 
generation of these mice has been described in 
detail previously (15). Conduction system-
specific Kir6.1 KO mice were generated by 
crossing mice with a conduction system-
specific cre, into which the tamoxifen-
inducible Cre-ERT2 had been ‘knocked-in’ into 
the HCN4 locus (HCN4-KiT cre) (17), with 
Kir6.1 homozygous floxed (Kir6.1(flx/flx)) 
mice. This generated HCN4cre+ Kir6.1 flx/flx 
(cKO) mice and HCN4cre- Kir6.1 flx/flx 
littermate controls. Recombination was 
induced with 1mg/day/25g mouse tamoxifen 
(Sigma-Aldrich) administration for 5 days 
(I.P). 
Genotyping - DNA was extracted from mouse 
ear biopsies by proteinase K digestion. The 
presence of the Kir6.1 floxed allele was 
confirmed using PCR with the following 
primer set: sense 5’-
GAGATCTTAACTCAGTTCTGGAGGACC
AACA-3’ and antisense 5’-
AGCGAAGAAAACTGCTTCCTGTTCATT
AAG-3’ yielding a WT band of 474 bp and a 






































conditions were denaturation at 94 ºC for 2 
minutes, 35 cycles of 94 ºC for 30 secs, 63 ºC 
for 30 secs, 68 ºC for 1 minute, extension at 68 
ºC for 8 minutes. The presence of the cre 
recombinase gene in the Kir6.1 conditional 
knock-out line was determined using the 




a band of 900 bp in cre positive mice and no 
band in cre negative mice. PCR cycle 
conditions were denaturation at 94 ºC for 2 
minutes, 35 cycles of 94 ºC for 1 minute, 60 ºC 
for 1 minute, 72 ºC for 1 minute, extension at 
72 ºC for 5 minutes. Both the floxed and cre 
PCRs used Taq polymerase (NEB, UK).  
Quantitative real-time PCR (qRT-PCR)- Total 
RNA was extracted from mouse tissues using 
the RNAeasy kit from Qiagen. Total RNA was 
DNase I treated and reverse-transcribed using 
the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). 50 ng 
of cDNA was used for qRT-PCR, which was 
performed using customised Taqman gene 
expression assays (Applied Biosystems). We 
used the commercially available probes for 
all the genes as listed below: 
Mm00434620_m1 for Kcnj8 (Kir6.1), 
Mm00440050_s1 for Kcnj11 (Kir6.2), 
Mm01701349_m1 for Abcc8 (SUR1), 
Mm00441638_m1 for Abcc9 (SUR2), 
Mm00801666_m1 for Cola1 (Collagen type 
I), Mm01254476_m1 for Col3a1 (Collagen 
type III), Mm01192933_g1 for Ctgf 
(Connective tissue growth factor), 
Mm01178820_m1 for Tgfb1 (Transforming 
growth factor β1), Mm00436955_m1 for 
Tgfb2 (Transforming growth factor β2), 
Mm01176086_m1 for Hcn4 (HCN4), 
Mm00468832_m1 for Hcn1 (HCN1), 
Mm004865672_m1 for Cacna1g (Cav3.1), 
Mm004382_m1 for Cacn1h (Cav3.2), 
Mm01188822_m1 for Cacn1c (Cav1.2), 
Mm00434618_m1 for Kcnj3 (Kir3.1), 
Mm01175829_m1 for Kcnj5 (Kir3.4) Each 
gene was assayed in triplicate. Relative 
expression was calculated by using the 
comparative CT method normalised to 
GAPDH. Final data are presented as a relative 
change compared to control. 
Isolation of SAN myocytes - SAN myocytes 
were isolated using the method of Mangoni 
and Nargeot ( 3 4 ) . B r i e f l y ,  mice were 
injected with heparin sodium (250 IU) and 
anaesthetised with a combination of ketamine 
(0.1 mg/g)/xylazine (0.01 mg/g). The hearts 
were rapidly excised and the SAN dissected 
and placed in Tyrode’s solution consisting of 
(in mM); 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 
MgCl2, 5 HEPES-NaOH, and 5.5 D-glucose 
(adjusted to pH 7.4 with NaOH). The SAN 
was then placed in low Mg2+/Ca2+ solution 
containing (in mM); 140 NaCl, 5.4 KCl, 0.5 
MgCl2, 0.2 CaCl2, 1.2 KH2PO4, 50 taurine, 5.5 
D-glucose, 1.0 mg/ml BSA, and 5.0 HEPES-
NaOH (adjusted to pH 6.9 with NaOH). The 
tissue was digested with 1 mg/mL 
Collagenase Type II (Worthington), 1 mg/mL 
Protease (Sigma-Aldrich), 1 mg/mL BSA 
(Sigma-Aldrich) and 200 μM CaCl2 for ~20 
mins at 37oC with consistent agitation with a 
fire-polished Pasteur pipette. The tissue was 
then washed 3-4 times in modified Kraft-
Bruhe (KB) solution containing (in mM): 70 
L-glutamic acid, 20 KCl, 80 KOH, 10 (±) D-
b-OH-butyric acid, 10 KH2PO4, 10 taurine, 1 
mg/ml BSA, and 10 HEPES-KOH, pH 7.4 
with KOH. SAN cells were dissociated 
manually using a fire-polished Pasteur pipette 
in KB solution and allowed to rest for 5 mins 
prior to re-adaptation. Cells were allowed to 
re-adapt to physiological levels of Na+ and 
Ca2+ by incremental addition of a solution 
containing 10 mM NaCl and 1.8 mM CaCl2 
and finally normal Tyrode’s solution with 1 
mg/mL BSA. Re-adapted cells were stored at 
room temperature in storage solution 
containing (in mM); 100 NaCl, 35 KCl, 1.3 
CaCl2, 0.7 MgCl2, 14 L-glutamic acid, 2 (±)D-
b-OH-butyric acid, 2 KH2PO4, 2 taurine, and 1 
mg/ml BSA, pH 7.4. SAN cells were plated 
onto 13 mm coverslips coated with laminin 30 
mins prior to patch-clamp recordings. 
Patch-clamp recordings from isolated SAN 
myocytes - Whole cell patch-clamp recordings 
were performed as described previously (15). 
Capacitance transients and series resistance in 
whole-cell recordings was compensated 
electronically by using amplifier circuitry 
(Axopatch 700B). Data were filtered at 1 kHz 
using the filter provided with the Axopatch 






































using a Digidata 1550 (Axon Instruments). 
Currents were acquired and analysed using 
pClamp10 (Axon Instruments). Whole-cell 
currents were recorded using a voltage-ramp 
protocol (-150 to +50 mV for 1 s). Pipette 
solution contained (mM); 107 KCl, 1 MgCl2, 
10 EGTA and 10 HEPES with 3 MgATP 
and 1 Na2ADP, pH 7.2 using KOH. The 
bath solution contained (mM); 137 NaCl, 5.4 
KCI, 1 MgCl2, 1.8 CaCl2, 5 Glucose, 10 
HEPES, pH 7.4 using NaOH. Drugs were 
applied to the bath using a gravity-driven 
perfusion system. Whole-cell action potentials 
were recorded using the current-clamp 
configuration. The pipette solution for current-
clamp recordings contained (mM); 110 K-
Gluconate, 20 KCl, 10 HEPES, 0.05 EGTA, 
0.5 MgCl2, 5 MgATP, 0.3 Na2-GTP, 5 Na2-
phosphocreatine, pH 7.4 using KOH. Data was 
initially analysed using Clampfit 10 (Axon 
Instruments). 
Masson’s Trichrome Staining - Trichrome 
staining was used to distinguish between 
muscle, collagen and connective tissue in 
serial 10 μM SAN sections embedded in 
paraffin. We used the Sigma-HT15 Trichrome 
Stain (Masson) Kit as per the manufacturer’s 
instructions (Sigma-Aldrich). 
ECG Telemetry - Briefly, recording leads were 
tunnelled subcutaneously in a conventional 
lead II ECG configuration connected to a 
telemetry device (TA-F10, Data Sciences 
International (DSI), Netherlands) implanted 
either subcutaneously or intra-abdominally. 
Surface ECG was continuously recorded via 
radio-telemetry after 2-weeks post-operative 
recovery. To record standard surface ECG 
parameters, consecutive individual ECG 
complexes recorded over 2 minutes during 
sinus rhythm at high sampling frequency (2 
kHz) were analysed using Ponemah P3 plus 
analysis software (DSI, Netherlands). Diurnal 
variation of heart rate was measured by 
averaging heart rate over a 12 hour period (7 
am to 7 pm (day) and 7 pm to 7 am (night)) 
corresponding to the light/dark cycle in the 
animal facility over at least a 48 hr period of 
recording. 
Analysis of Heart Rate Variability - Changes 
in the R-R interval variability were analysed 
using the heart rate variability module (HRV) 
in LabChart v7.0 (AD Instruments). ECG 
recordings taken at a low activity period 
(12pm-2pm) were analysed using power 
spectral analysis as described previously (35). 
R-waves were detected using a threshold-
sensing algorithm and ectopic beats were 
excluded from the analysis. Fast Fourier 
transformation was performed using 1024 
spectral points and a half overlap within a 
Welch window and power spectral density 
plots determined. The total power (TP) (s2/Hz) 
was calculated as the integral sum of total 
variability after Fourier transformation over 
the frequency range 0-4.0 Hz. Cut-off 
frequencies determined to be accurate for mice 
were used to divide the signal into three 
components, very low frequency (VLF: 0.0 - 
0.4 Hz), low frequency (LF: 0.4 - 1.5 Hz), and 
high frequency (HF: 1.5 - 4.0 Hz). Data from 
segments was also normalized to exclude 
VLF. Normalized low frequency (nLF) = 
LF/(TP-VLF) x 100 and normalized high 
frequency (nHF) = HF/(TP-VLF) x 100.  
Multi-Electrode-Array (MEA) Recordings - 
MEA recordings were taken from atrial/SAN 
preparations and from the intact heart. We 
used 2 types of MEAs to record spontaneous 
electrical activity (field potentials) from in 
vitro atrial preparations (60-electrode MEA, 
60pMEA200/30iR-Ti & MEA2100 system 
Multi Channel Systems, Reutlingen, 
Germany), and the intact heart (32 electrodes 
flexMEA, Multi Channel Systems). Details of 
electrophysiological recordings with the 
MEA2100 system have been described 
previously (36). Briefly, the right atrial 
appendage and SA node were carefully and 
quickly dissected from the heart following 
excision and placed on the MEA dish and 
secured for good contact with electrodes with 
a holder. Tissue was continuously perfused 
with warm (37ºC) and oxygenated (95% 
O2/5% CO2) Krebs solution (consisting of 
mM; NaCl 118, KCl 4.75, MgSO47H20 1.19, 
NaHCO3 25, KH2PO4 1.19, D-glucose 5 mM, 
CaCl2 1.4 and sodium pyruvate 2 mM). The 
tissue was allowed to equilibrate for 30 
minutes prior to recording of spontaneous 
extracellular field potentials using MC Rack 
software (v4.6.2, Multi Channel Systems). 
 For experiments on intact isolated 
heart preparations, hearts were excised as 






































mounted onto a modified Langendorff setup. 
Hearts were continuously retrogradely 
perfused with Krebs (as above). The flexMEA 
was placed on the boundary of the right 
ventricle and right atria allowing for 
measurement of spontaneous electrical signals 
from both atria and ventricles using MC Rack 
software. Sinus node recovery time (SNRT) 
was measured using the flexMEA and a 
unipolar electrode to pace at S1S1 cycle 
lengths of 100 ms. SNRT was measured from 
the last pacing spike to the first atrial signal. 
Data was analysed using LabChart v7 and 
Clampfit v10. 
Statistical Analysis – Data are presented as 
mean ± SEM. Data was analysed using 
Microsoft Excel (Microsoft), Microcal Origin 
and GraphPad Prism. Student’s t test and 
ANOVA were used to compare means where 
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Table 1. Action potential parameters recorded from isolated SAN cells 
AP Parameters WT (n=15/9) cKO (n=11/7) 
RMP (mV) 
MDP (mV) 
Time to Peak (ms) 
Amplitude (mV) 
Peak amplitude (mV) 
dV/dt (mV/ms) 
-48.7 ± 2.2  
-52.6 ± 1.5  
140.1 ± 12.0 
65.9 ± 6.9 
15.6 ± 5.5 
0.4 ± 0.0 
-51.8 ± 2.3 
-54.1 ± 2.3 
186.6 ± 14.2* 
78.2 ± 8.4* 
26.6 ± 6.5 
0.4 ± 0.1 
 
RMP= resting membrane potential, MDP= maximum diastolic potential. 









































Figure 1. Generation and characterisation of the conduction system-specific knockout mouse 
(cKO). A, Cre-LoxP targeting strategy for the deletion of exon 2 of the Kcnj8 gene. A targeting 
vector construct for Kcnj8 with a 5’ loxP site together with a FRT-flanked neomycin (Neo) selection 
cassette within intron 1 upstream of exon 2 and the second loxP site in intron 2 and diptheria toxin A 
(DTA) negative selection marker downstream. Mice with the recombined Kcnj8 locus were crossed 
with global flp-deleter mice to allow Flp-mediated excision of the neomycin selection cassette and 
generate Kir6.1 (+/flx) offspring. Kir6.1 (flx/flx) mice were then crossed with mice in which the cre 
recombinase expression is driven by a tamoxifen inducible HCN4 promoter to produce HCN4cre+ 
Kir6.1(flx/flx) (cKO) mice. B, PCR of the cre recombinase (top) from mouse ear biopsies and of the 
floxed allele (bottom) of DNA isolated from SAN, ventricles, left atria and aorta of cKO mice before 
and after tamoxifen administration. C, Relative levels of expression of Kir6.1 (Kcnj8), Kir6.2 
(Kcnj11), SUR1 (Abcc8) and SUR2 (Abcc9) in the SAN, left atria (LA) and ventricles (VT) from WT 
and cKO mice. The gene expression level in each case was normalized to the WT. Data is shown as 
mean ± S.E.M, n=5 mice, **P<0.01 compared to WT  
 
Figure 2. Deletion of Kir6.1 in the conduction system results in loss of K
ATP
 current in SAN cells. 
A, Representative time-course traces at +40 mV (right panel) and whole-cell current density-voltage 
traces (left panel) taken from SAN cells isolated from WT and cKO mice following tamoxifen 
induction showing the effects of pinacidil (Pin), diazoxide (DZX), tolbutamide (TOL) and 
glibenclamide (Glib). The control (Con) trace is shown in grey. Current-voltage relationships were 
recorded using a 1s ramp protocol (-150 mV to -+50 mV) from a holding potential of -80 mV. B, 
Summary of the mean current-densities at +40 mV from ECs isolated from WT (top) and cKO 
(bottom) mice. C, Proportion of WT (n=29) and cKO (n=18) SAN cells responsive to pinacidil and/or 
diazoxide. D, Mean tolbutamide-sensitive current recorded from SAN cells isolated from WT and 
cKO mice. n=9-12 cells from 3-10 mice. Data is shown as mean ± S.E.M.  *P<0.05 compared to 
control/WT. 
 
Figure 3. Tamoxifen-induced Kir6.1 deletion in SAN leads to bradycardia in cKO mice. 
Representative 2 lead ECG traces from conscious freely-moving WT (A) and cKO (B) mice before 
and after tamoxifen administration. Expanded traces (inset) show changes in PR interval before 
(black) and after (grey) tamoxifen administration. Mean heart rate (HR), PR and RR interval 
determined from ECGs recorded over a 48hr period from WT (C) and cKO (D) mice. E, Example 
trace from a cKO mouse showing sinus node dysfunction characterised by pronounced bradycardia 
and episodes of sinus pauses. F, Mean data showing the number of RR intervals greater than 200 ms 
in WT and cKO mice. n=7-8 mice. **P<0.01 compared to WT. 
 
Figure 4. Heart rate variability does not contribute to the bradycardic phenotype in cKO mice. 
Representative frequency domain power spectral density plots from WT (A) and cKO (B) mice. HF 
indicates high-frequency band (1.5–4 Hz); LF, low-frequency band (0.4–1.5 Hz); and VLF, very-low 
frequency band (0–0.4 Hz). C, Mean normalised data comparing VF and HF before and after 
tamoxifen administration in WT and cKO mice. D, Mean total power before and after tamoxifen 







































Figure 5. Action potential firing rate is reduced and action potential duration (APD) prolonged 
in isolated pacemaker cells from cKO mice. A, Representative train of spontaneous action 
potentials recorded from isolated WT and cKO SAN cells using whole-cell current clamp. B, 
Representative single action potentials from a WT (black) and cKO (grey) SAN cell. C&D, Observed 
spontaneous rates prior to electrophysiological recording (C) and recorded beat frequency after 
establishment of the whole configuration (D) in SAN cells from WT and cKO mice. E, Mean APD 
values for APD20 (the duration of the action potential measured at 20% of the amplitude) to APD100 
for action potentials from WT and cKO SAN cells. n=11-15 cells from 7-9 mice. F, Mean APD90/50 
values for APs from WT and cKO cells. G, Mean APD30-40/APD70-80 values for APs from WT and 
cKO cells. n=11-15 cells from 7-9 mice. Data is shown as mean ± S.E.M.  *P<0.05, **P<0.01, 
***P0.001 compared to control/WT. 
 
Figure 6. Reduced beat frequency in intact right atrial/SAN preparations and increased SNRT 
in intact hearts from cKO mice. A, Representative field potentials from WT and cKO right atrial 
(RA) tissue with the SAN intact recorded using 2-D MEA. B, Mean beat frequency from RA/SAN 
tissue from WT (n=11) and cKO (n=12) mice. C, SNRT was measured using a flexMEA on isolated 
heart preparations. Hearts were paced for 20 s at S1S1 cycle lengths of 100 ms and defined as the time 
interval from the last pacing spike to the first recorded atrial activity. Hearts were challenged with 
hypoxia (95% N2) and reperfusion. D, Mean basal SNRT measured from WT (n=12) and cKO (n=10) 
hearts. E, Mean relative SNRT during hypoxia and reperfusion in WT (n=12) and cKO (n=10) hearts. 
Data is shown as mean ± SEM. *P<0.05 compared WT. 
 
Figure 7. SANs from cKO mice are hypomorphic with increased expression of pro-fibrotic 
markers. Representative images of Mason’s trichrome staining of SAN from WT (A) and cKO (B) 
mice. C, Relative expression of pro-fibrotic markers in WT and cKO SAN tissue. n=5. Data is shown 
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